Ingen internetforbindelse — viser den gemte version af siden.

Silence Therapeut…

USUSD
← Til screeneren

Silence Therapeutics PLC (US:SLNCF) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
silence-therapeutics.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
LONDON, United Kingdom
Administrerende direktør
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Ansatte
88
Udestående aktier
141.74 mio. pr. 2026-07-31
Free float
37.84 mio.
Markedsværdi
665.67 mio. USD
Insidere
7.97%
Institutionelle investorer
39.68%
Branche (SIC)
Pharmaceutical Preparations
Beskrivelse

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksSLNCFUSD4 +0.00%almindelige aktier

Kurs over 3 måneder

US:SLNCF · USD
stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 07.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
Siren, L.L.C.5.5%3.31 mio.2026-06-30
TCG Crossover Management…5.04%3.03 mio.2026-06-30
Redmile Group, LLC3.6%2.16 mio.2026-06-30
Nantahala Capital Manage…2.24%1.35 mio.2026-06-30
Citadel Advisors Llc2.21%1.33 mio.2026-06-30
Nextech Invest, Ltd.1.58%952 4002026-06-30
Millennium Management Ll…1.51%909 2792026-06-30
Ikarian Capital, LLC1.38%830 7842026-06-30
Tetragon Partners GP Ltd…1.27%764 2562026-06-30
Soleus Capital Managemen…1.05%630 0002026-06-30
Fidelity Advisor Series…0.8%482 0882026-07-31
iShares Trust-iShares Bi…0.39%234 0092026-08-31
ALGER FUNDS-Alger Small…0.18%105 6792026-07-31
Fidelity Select Portfoli…0.17%103 9122026-07-31
ALGER INSTITUTIONAL FUND…0.07%41 2922026-07-31
Fidelity Concord Street…0.05%29 5382026-07-31
SPDR INDEX SHARES Fd.S-S…0.02%9 5322026-06-30
Trust for Professional M…0.01%8 6952026-05-31
Steward Funds Inc-Stewar…0.01%5 8002026-07-31
Invesco Exchange-Traded…0%2 9182026-08-31